To address this gap, we conducted a retrospective cohort study evaluating the risk of new‐onset NASH and liver cirrhosis in patients treated with GLP‐1 RAs versus those who underwent bariatric surgery. Here, GCG is linked to metabolic dysfunction-associated steatohepatitis.